On Tuesday, Ariad Pharmaceuticals Inc.'s stock plummeted to finish at $4.68, down 8.79% from the prior day's closing price of $5.13. The company's shares fluctuated between $4.56 and $5.62 during the trading session. A total of 78.75 million shares were traded, which is above the daily average volume of 14.37 million. Despite Tuesday's pullback, the company's shares have rallied 67.74% in the previous three trading sessions and 31.46% in the last one month, outperforming the S&P 500, which has gained 0.38% and 2.44% during the respective periods. Furthermore, Ariad Pharmaceuticals Inc.'s stock is trading below its 50-day and 200-day moving averages of $8.40 and $16.29, respectively.
www.nasdaq.com/press-release/...d-mannkind-corp-20131127-00223